logo

Cohance Lifesciences Ltd. Financials

15:59 Oct 29

Cohance Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
786.45
-73.25 (-8.52%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Cohance Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
786.45
-73.25 (-8.52%)
15:59 Oct 29
Quality
image/svg+xml

36/100
Medium Financial Strength

Valuation
image/svg+xml

22/100
Expensive Valuation

Technical

30/100
Technically Bearish

Strength

3

Weakness

14

Opportunity

1

Threats

0

15.78 %

ROE %

8.83 %

ROA %

6.69

EPS

66.64

BVPS

22.36 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1320.22 1340.33 1051.35 1197.58 1516.2
Operating Expenses +
740.79 773.79 645.54 822.38 1108.92
Raw Material
459.46 430.08 265.88 222.66 362.69
Increase Decrease in Cost
-60.35 -20.94 49.16 82.63 27.14
Other Manufacturing Expense
173.19 176.29 133.48 0 0
Employee Cost
100.48 110.51 135.92 249.56 337.56
Miscellaneous Expenses
68.01 77.85 61.1 267.53 381.53
Operating Profit
579.43 566.54 405.81 375.2 407.28
Other Income
92.38 46.36 61.91 58.56 54.57
Depreciation
39.1 47.73 54.6 77.49 109.23
Interest
6.23 5.44 7.45 12.35 20.93
Profit before tax and exceptio..
626.48 559.73 405.67 343.92 331.69
Exceptional Items
0 0 0 0 -8.1
PBT
626.48 559.73 405.67 343.92 339.79
Provision for Taxation
213.78 148.44 105.39 79.15 73.19
Net Profit
412.69 411.29 300.28 264.77 250.4
NET Profit after MI
453.8 411.29 300.28 267.87 255.98
EPS
17.83 16.16 11.8 10.52 9.42
Operating Profit Margin (%)
43.89 42.27 38.6 31.33 26.86
Net Profit Margin (%)
34.37 30.69 28.56 22.37 16.88

Cohance Lifesciences Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Sep 25 Jun 25 Mar 25 Dec 24 Sep 24
Promoter 57.50 66.40 50.10 50.10 50.10
FII 6.50 7.20 11.00 10.80 10.70
MF 16.50 8.90 13.00 13.20 14.10
Others 4.30 2.50 3.70 3.50 2.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: